Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice
- PMID: 9926292
- DOI: 10.1097/00008469-199812000-00004
Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice
Abstract
Low gastric juice total vitamin C concentration in the presence of Helicobacter pylori (H. pylori) infection probably plays a role in gastric carcinogenesis. In vitro vitamin C has been shown to inhibit the growth of H. pylori. The aims of this study were to determine the effect of high dose vitamin C administration on H. pylori infection and on gastric juice total vitamin C concentration in patients with H. pylori related chronic gastritis. Sixty patients with dyspeptic symptoms and proven chronic gastritis and H. pylori infection, who were undergoing routine endoscopy, entered the study after giving informed consent. They were randomly coded into two treatment groups. Group 1 (controls, n = 28) were treated with antacids for 4 weeks and Group 2 (n = 32) received vitamin C 5g daily also for 4 weeks. Nine patients did not complete the study and were excluded. Plasma and gastric juice total vitamin C levels were measured at baseline, at the end of 4 weeks treatment and again 4 weeks after treatment cessation. In the control group H. pylori infection remained unchanged in all 24 patients throughout as did the mean gastric juice total vitamin C concentration. However, in the vitamin C treated group eight of 27 patients (30%) who completed the treatment course the H. pylori infection was eradicated (P = 0.01). In these patients the mean gastric juice total vitamin C concentration rose significantly from 7.2 +/- 1.6 micrograms/ml after 4 weeks treatment (P < M 0.001) and 19.8 micrograms/ml 4 weeks after treatment was discontinued (P < 0.001). In the remaining 19 patients with persistent H. pylori infection, the mean gastric juice total vitamin C concentration rose less than in those with successful H. pylori eradication; 6.3 +/- 1.7 micrograms/ml before treatment, 10.8 +/- 1.5 micrograms/ml after 4 weeks treatment (P < 0.05) and a return to pre-treatment levels (7.1 +/- 2.7 micrograms/ml) 4 weeks after vitamin C intake stopped. There were no side effects of vitamin C treatment. This study has shown that 4 weeks daily high dose vitamin C treatment in H. pylori infected patients with chronic gastritis resulted in apparent H. pylori eradication in 30% of those treated. In those patients there was also a highly significant rise in gastric juice total vitamin C concentration which persisted for at least 4 weeks after the treatment ceased. A significant, though less marked, gastric juice total vitamin C concentration increase was observed during vitamin C treatment even in subjects with persistent H. pylori infection, though this was not maintained after treatment ended. The mechanism whereby vitamin C treatment appeared to result in H. pylori eradication is unclear. Further confirmatory studies are indicated.
Similar articles
-
Tobacco smoking and vitamin C concentration in gastric juice in healthy subjects and patients with Helicobacter pylori infection.Eur J Cancer Prev. 2000 Dec;9(6):423-8. doi: 10.1097/00008469-200012000-00008. Eur J Cancer Prev. 2000. PMID: 11201681 Clinical Trial.
-
Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication.Dig Dis Sci. 1995 Mar;40(3):615-21. doi: 10.1007/BF02064380. Dig Dis Sci. 1995. PMID: 7895555
-
Relationship of Helicobacter pylori CagA(+) status to gastric juice vitamin C levels.Eur J Clin Invest. 1999 Jan;29(1):56-62. doi: 10.1046/j.1365-2362.1999.00432.x. Eur J Clin Invest. 1999. PMID: 10092990
-
Pathways of Gastric Carcinogenesis, Helicobacter pylori Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals.Int J Mol Sci. 2020 Sep 3;21(17):6451. doi: 10.3390/ijms21176451. Int J Mol Sci. 2020. PMID: 32899442 Free PMC article. Review.
-
Vitamin C, Helicobacter pylori infection and gastric carcinogenesis.Int J Vitam Nutr Res. 1999 May;69(3):220-7. doi: 10.1024/0300-9831.69.3.220. Int J Vitam Nutr Res. 1999. PMID: 10389031 Review. No abstract available.
Cited by
-
Association between dietary antioxidant index and risk of Helicobacter pylori infection among adults: a case-control study.BMC Gastroenterol. 2022 Sep 6;22(1):413. doi: 10.1186/s12876-022-02488-3. BMC Gastroenterol. 2022. PMID: 36068529 Free PMC article.
-
Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies.Molecules. 2021 Oct 8;26(19):6078. doi: 10.3390/molecules26196078. Molecules. 2021. PMID: 34641620 Free PMC article. Review.
-
Vegetable Extracts and Nutrients Useful in the Recovery from Helicobacter pylori Infection: A Systematic Review on Clinical Trials.Molecules. 2021 Apr 14;26(8):2272. doi: 10.3390/molecules26082272. Molecules. 2021. PMID: 33919894 Free PMC article.
-
Molecular Mechanisms Contributing Bacterial Infections to the Incidence of Various Types of Cancer.Mediators Inflamm. 2020 Jul 8;2020:4070419. doi: 10.1155/2020/4070419. eCollection 2020. Mediators Inflamm. 2020. PMID: 32724295 Free PMC article. Review.
-
Vitamin C: A Preventative, Therapeutic Agent Against Helicobacter pylori.Cureus. 2018 Jul 30;10(7):e3062. doi: 10.7759/cureus.3062. Cureus. 2018. PMID: 30280058 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical